European Heart Valve Device Market to Grow at More Than 10 Percent Annually Through 2016

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the aging population of Europe, coupled with greater use of premium-priced transcatheter heart valve (THV) devices will enable the combined heart valve device markets in France, Germany, Italy and the United Kingdom to grow at an average rate of greater than ten percent per year through 2016.

“The main innovation in heart valve devices will come in transcatheter devices”

The introduction of THV devices in Europe has enabled patients who are ineligible for surgery to have heart valves replaced or repaired. This new pool of patients has lead to extremely strong procedure growth that will continue through 2016, with the rate dropping by 2016 as this population becomes increasingly penetrated. Growth will be further driven by the increasing size of the over-65 demographic in Europe because this population is most susceptible to heart valve disease, and are often ineligible for surgery.

Germany has the largest heart valve device market among the four countries, providing nearly half of total European revenues, in part because it has the largest and oldest population. Germany’s stronger reimbursements for new technology and the willingness of German physicians to adopt innovative procedures are other factors supporting the country’s large market size.

“The main innovation in heart valve devices will come in transcatheter devices,” said MRG Analyst Ian Swanson. “Two new competitors, JenaValve and Symetis, entered the market in 2011, with improvements in valve positioning and ease of implantation. More entrants are expected in the next 12 to 16 months. Of course, a successful small company will become an acquisition target for a larger, more established competitor. For example, Boston Scientific purchased transcatheter aortic valve replacement (TAVR) device developer Sadra Medical in 2010 to speed its entry into the market.”

European THV devices are currently dominated by three companies: Abbott Vascular, Edwards Lifesciences, and Medtronic.

Millennium Research Group’s European Markets for Heart Valve Devices 2012 report includes unit, average selling price and revenue information, along with market drivers and limiters and competitive landscape for tissue heart valves, mechanical heart valves, annuloplasty devices and THV devices in France, Germany, Italy and the United Kingdom.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.